Business Relations Table - o4.fyi ()

Anmelden Gast|Guest
Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

Domain-Statistiken für "delveinsight.com"

301
Business Relations
302
Eindeutige Domains
20
Gefundene Einträge
BR-Relations: 301
From Domain Role To Domain Path Aktionen
/blog/there-is-no-fda-approved-drug-for-chemo-diarrhea-here-is-what-fills-the-gap
/treatment-resistant-depression-market-to-rising-at-a-cagr-of-15-driven-by-recent-advancements-in-clinical-trials/
/latest/global-digital-health-market-poised-for-robust-growth-at-a-cagr-of-18-by-2032-amid-rising-demand-for-remote-care-delveinsight-2/
/story/499688/ulcerative-colitis-pipeline-analysis-2023-covering-clinical-trials-emerging-therapies-fda-ema-and-pmda-approvals-competitive-landscape-eli-lilly-abbvie-pfizer-arena-pharma-janssen.html
/biotech/bispecific-and-trispecific-antibodies-market-to-observe-stupendous-growth-by-2035-predicts-delveinsight-key-companies-akeso-summit-therapeutics-zymeworks-beigene-jazz-pharmaceuticals-merus/
/linkedin-competitor-benchmarking/
/archives/182124
/story/202232/pulmonary-arterial-hypertension-market-set-for-significant-growth-by-2036-driven-by-emerging-targeted-therapies-and-rising-diagnosis-rates-delveinsight.html
/story/189856/chronic-inflammatory-demyelinating-polyneuropathy-market-set-for-significant-growth-by-2036-driven-by-emerging-targeted-therapies-and-rising-diagnosis-rates-delveinsight.html
/story/202571/chronic-inflammatory-demyelinating-polyneuropathy-market-set-for-significant-growth-by-2036-driven-by-emerging-targeted-therapies-and-rising-diagnosis-rates-delveinsight.html
/story/174059/chronic-inflammatory-demyelinating-polyneuropathy-market-set-for-significant-growth-by-2036-driven-by-emerging-targeted-therapies-and-rising-diagnosis-rates-delveinsight.html
/story/740652/pulmonary-arterial-hypertension-market-set-for-significant-growth-by-2036-driven-by-emerging-targeted-therapies-and-rising-diagnosis-rates-delveinsight.html
/story/391477/chronic-inflammatory-demyelinating-polyneuropathy-market-set-for-significant-growth-by-2036-driven-by-emerging-targeted-therapies-and-rising-diagnosis-rates-delveinsight.html
/story/195826/chronic-inflammatory-demyelinating-polyneuropathy-market-set-for-significant-growth-by-2036-driven-by-emerging-targeted-therapies-and-rising-diagnosis-rates-delveinsight.html
/usa-business-detail-in-Nevada-NV-21-Las-Vegas/DelveInsight-Business-Research-38440
/story/194348/chronic-inflammatory-demyelinating-polyneuropathy-market-set-for-significant-growth-by-2036-driven-by-emerging-targeted-therapies-and-rising-diagnosis-rates-delveinsight.html
/press
/beyond-the-bots-10-surprising-ai-innovations-you-absolutely-missed-in-2024-2025/
/2022/11/29/6-prescription-digital-therapeutics-story-angles-to-explore/
/posts/10-must-have-esthetician-devices-for-spa-success-in-2025